New enema treatments for inflammatory bowel disease
- 1 March 1988
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 33 (S3) , 85S-87S
- https://doi.org/10.1007/bf01538136
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processesImmunopharmacology, 1986
- Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patientsImmunopharmacology, 1986
- SulfasalazineAnnals of Internal Medicine, 1984
- Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal applicationClinical Pharmacology & Therapeutics, 1983
- Sulfasalazine-Induced Exacerbation of Ulcerative ColitisNew England Journal of Medicine, 1982
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Absorption, metabolism, and excretion of salicylazosulfapyridine in manClinical Pharmacology & Therapeutics, 1972